Piramal Enterprises Limited (PEL.NS)
INR 967.95
(1.38%)
INR 967.95
(1.38%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 826.05 Billion INR | -98.23% |
| 2022 | 46768.2 Billion INR | 4582.77% |
| 2021 | 998.72 Billion INR | 29.51% |
| 2020 | 771.18 Billion INR | 2.95% |
| 2019 | 749.08 Billion INR | -12.52% |
| 2018 | 856.26 Billion INR | 17.81% |
| 2017 | 726.83 Billion INR | 50.67% |
| 2016 | 482.39 Billion INR | 56.44% |
| 2015 | 308.35 Billion INR | 47.29% |
| 2014 | 209.35 Billion INR | -2.59% |
| 2013 | 214.92 Billion INR | 6.12% |
| 2012 | 202.53 Billion INR | 37.8% |
| 2011 | 146.96 Billion INR | 5.95% |
| 2010 | 138.71 Billion INR | 260.05% |
| 2009 | 38.52 Billion INR | 6.65% |
| 2008 | 36.12 Billion INR | 43.87% |
| 2007 | 25.1 Billion INR | 8.3% |
| 2006 | 23.18 Billion INR | 24.2% |
| 2005 | 18.66 Billion INR | 41.83% |
| 2004 | 13.16 Billion INR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 867.56 Billion INR | 0.0% |
| 2024 Q1 | - INR | -100.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q4 | 826.05 Billion INR | 0.0% |
| 2023 FY | 826.05 Billion INR | -98.23% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q2 | 816.45 Billion INR | 0.0% |
| 2022 Q2 | 803.89 Billion INR | 0.0% |
| 2022 Q4 | 46768.2 Billion INR | 5899.77% |
| 2022 FY | 46768.2 Billion INR | 4582.77% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q3 | 779.5 Billion INR | -3.03% |
| 2021 Q4 | 998.72 Billion INR | 0.0% |
| 2021 Q2 | 1053.74 Billion INR | 0.0% |
| 2021 FY | 998.72 Billion INR | 29.51% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q1 | - INR | -100.0% |
| 2020 FY | 771.18 Billion INR | 2.95% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q2 | 766.76 Billion INR | 0.0% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q4 | 771.18 Billion INR | 0.0% |
| 2019 FY | 749.08 Billion INR | -12.52% |
| 2019 Q2 | 818.55 Billion INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q4 | 749.08 Billion INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2018 Q1 | - INR | -100.0% |
| 2018 Q2 | 805.52 Billion INR | 0.0% |
| 2018 Q3 | - INR | -100.0% |
| 2018 Q4 | 856.26 Billion INR | 0.0% |
| 2018 FY | 856.26 Billion INR | 17.81% |
| 2017 Q2 | 566.22 Billion INR | 0.0% |
| 2017 Q3 | 630.56 Billion INR | 11.36% |
| 2017 Q4 | 726.83 Billion INR | 15.27% |
| 2017 Q1 | - INR | -100.0% |
| 2017 FY | 726.83 Billion INR | 50.67% |
| 2016 Q1 | - INR | -100.0% |
| 2016 FY | 482.39 Billion INR | 56.44% |
| 2016 Q4 | 482.39 Billion INR | 0.0% |
| 2016 Q3 | - INR | -100.0% |
| 2016 Q2 | 459.81 Billion INR | 0.0% |
| 2015 Q1 | - INR | -100.0% |
| 2015 FY | 308.35 Billion INR | 47.29% |
| 2015 Q4 | 308.35 Billion INR | 0.0% |
| 2015 Q3 | - INR | -100.0% |
| 2015 Q2 | 257.89 Billion INR | 0.0% |
| 2014 Q1 | - INR | -100.0% |
| 2014 Q4 | 209.35 Billion INR | 0.0% |
| 2014 FY | 209.35 Billion INR | -2.59% |
| 2014 Q3 | - INR | -100.0% |
| 2014 Q2 | 193.43 Billion INR | 0.0% |
| 2013 Q3 | - INR | -100.0% |
| 2013 Q2 | 217.5 Billion INR | 0.0% |
| 2013 Q1 | - INR | -100.0% |
| 2013 FY | 214.92 Billion INR | 6.12% |
| 2013 Q4 | 214.92 Billion INR | 0.0% |
| 2012 FY | 202.53 Billion INR | 37.8% |
| 2012 Q4 | 202.53 Billion INR | 0.0% |
| 2012 Q3 | - INR | -100.0% |
| 2012 Q2 | 189.88 Billion INR | 0.0% |
| 2011 Q4 | 146.96 Billion INR | 0.0% |
| 2011 FY | 146.96 Billion INR | 5.95% |
| 2010 FY | 138.71 Billion INR | 260.05% |
| 2009 FY | 38.52 Billion INR | 6.65% |
| 2008 FY | 36.12 Billion INR | 43.87% |
| 2007 FY | 25.1 Billion INR | 8.3% |
| 2006 FY | 23.18 Billion INR | 24.2% |
| 2005 FY | 18.66 Billion INR | 41.83% |
| 2004 FY | 13.16 Billion INR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Aarti Drugs Limited | 24.32 Billion INR | -3296.084% |
| Aarti Pharmalabs Limited | 25.82 Billion INR | -3099.14% |
| Albert David Limited | 4.97 Billion INR | -16487.633% |
| Alembic Limited | 23.28 Billion INR | -3447.152% |
| Biofil Chemicals and Pharmaceuticals Limited | 470.82 Million INR | -175346.608% |
| Hester Biosciences Limited | 6.62 Billion INR | -12371.559% |
| Hikal Limited | 24.87 Billion INR | -3221.285% |
| Ind-Swift Laboratories Limited | 11.65 Billion INR | -6989.911% |
| Ind-Swift Limited | 6.54 Billion INR | -12521.638% |
| IOL Chemicals and Pharmaceuticals Limited | 22.44 Billion INR | -3580.494% |
| Kilitch Drugs (India) Limited | 2.4 Billion INR | -34309.918% |
| Lincoln Pharmaceuticals Limited | 7 Billion INR | -11695.821% |
| Mangalam Drugs & Organics Limited | 3.33 Billion INR | -24674.746% |
| Medico Remedies Limited | 961.95 Million INR | -85772.179% |
| Morepen Laboratories Limited | 12.93 Billion INR | -6287.618% |
| Procter & Gamble Health Limited | 7.94 Billion INR | -10298.938% |
| RPG Life Sciences Limited | 5.12 Billion INR | -16006.421% |
| Sigachi Industries Limited | 6.94 Billion INR | -11800.054% |
| Sun Pharmaceutical Industries Limited | 854.62 Billion INR | 3.344% |
| Suven Pharmaceuticals Limited | 22.54 Billion INR | -3564.677% |
| Themis Medicare Limited | 5.66 Billion INR | -14483.791% |
| Unichem Laboratories Limited | 31.69 Billion INR | -2506.375% |
| Vaishali Pharma Limited | 799.55 Million INR | -103213.46% |
| Venus Remedies Limited | 6.26 Billion INR | -13078.214% |
| Windlas Biotech Limited | 6.26 Billion INR | -13091.346% |
| ZIM Laboratories Limited | 4.46 Billion INR | -18387.215% |
| Alembic Pharmaceuticals Limited | 64.45 Billion INR | -1181.576% |
| Bafna Pharmaceuticals Limited | 1.47 Billion INR | -55834.524% |
| FDC Limited | 24.68 Billion INR | -3246.92% |
| Gufic Biosciences Limited | 10.92 Billion INR | -7460.81% |
| Jubilant Pharmova Limited | 115.48 Billion INR | -615.288% |
| Nectar Lifesciences Limited | 21.91 Billion INR | -3670.099% |
| Orchid Pharma Limited | 15.53 Billion INR | -5216.068% |
| Alkem Laboratories Limited | 155.74 Billion INR | -430.373% |
| Bajaj HealthCare Limited | 7.65 Billion INR | -10696.237% |
| Brooks Laboratories Limited | 904.45 Million INR | -91231.345% |
| Eris Lifesciences Limited | 70.48 Billion INR | -1071.895% |
| Glenmark Life Sciences Limited | 28.5 Billion INR | -2798.002% |
| Solara Active Pharma Sciences Limited | 23.46 Billion INR | -3420.199% |
| Innova Captab Limited | 13.2 Billion INR | -6153.781% |
| Jagsonpal Pharmaceuticals Limited | 2.17 Billion INR | -37953.142% |
| Wanbury Limited | 3.43 Billion INR | -23948.518% |
| Lupin Limited | 239.97 Billion INR | -244.228% |
| Sakar Healthcare Limited | 3.88 Billion INR | -21153.844% |
| Aurobindo Pharma Limited | 450.71 Billion INR | -83.275% |
| Divi's Laboratories Limited | 154.7 Billion INR | -433.969% |
| AstraZeneca Pharma India Limited | 10.78 Billion INR | -7562.6% |
| Mankind Pharma Limited | 119.63 Billion INR | -590.489% |
| Sequent Scientific Limited | 15.4 Billion INR | -5262.624% |
| Laurus Labs Limited | 83.87 Billion INR | -884.914% |
| Neuland Laboratories Limited | 18.32 Billion INR | -4407.626% |
| J. B. Chemicals & Pharmaceuticals Limited | 39.94 Billion INR | -1968.16% |
| Glenmark Pharmaceuticals Limited | 143.58 Billion INR | -475.299% |
| Zydus Lifesciences Limited | 292.8 Billion INR | -182.113% |
| Amrutanjan Health Care Limited | 3.66 Billion INR | -22416.107% |
| Wockhardt Limited | 76.49 Billion INR | -979.945% |
| Bal Pharma Limited | 3.2 Billion INR | -25682.72% |
| Dr. Reddy's Laboratories Limited | 387.51 Billion INR | -113.164% |
| Bliss GVS Pharma Limited | 12.13 Billion INR | -6705.103% |
| Par Drugs and Chemicals Limited | 1.01 Billion INR | -81195.252% |
| Caplin Point Laboratories Limited | 26.97 Billion INR | -2962.416% |
| Shilpa Medicare Limited | 30.93 Billion INR | -2570.531% |
| Valiant Laboratories Limited | 3.42 Billion INR | -24005.066% |
| Ajanta Pharma Limited | 46.38 Billion INR | -1680.898% |
| Aarey Drugs & Pharmaceuticals Limited | 3.04 Billion INR | -26984.306% |
| Granules India Limited | 55.2 Billion INR | -1396.201% |
| Medicamen Biotech Limited | 2.94 Billion INR | -27947.103% |
| Ipca Laboratories Limited | 111.01 Billion INR | -644.103% |
| Syncom Formulations (India) Limited | 4.04 Billion INR | -20313.237% |
| Torrent Pharmaceuticals Limited | 150.61 Billion INR | -448.47% |
| NATCO Pharma Limited | 69.06 Billion INR | -1096.082% |
| Suven Life Sciences Limited | 2.84 Billion INR | -28894.109% |
| Krebs Biochemicals & Industries Limited | 1.78 Billion INR | -46261.801% |
| Strides Pharma Science Limited | 58.39 Billion INR | -1314.529% |
| Indoco Remedies Limited | 21.44 Billion INR | -3751.534% |
| Alpa Laboratories Limited | 1.82 Billion INR | -45132.85% |
| Lasa Supergenerics Limited | 1.5 Billion INR | -54652.908% |
| Sun Pharma Advanced Research Company Limited | 5.15 Billion INR | -15938.56% |